Leerink Partners Cuts Price Target on Alexion Pharma (ALXN) to $216; Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- Wall St rises on AI gains as oil slides, Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips briefly below $100 on Saudi exports, hopes of US-Iran diplomacy
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Qatar Investment Authority targets $20B partnership with JPMorgan - Bloomberg
- AMD stock jumps as chip rally builds ahead of summit
Biotechs Continue to Underperform (IBB)
March 17, 2016 10:28 AM EDTBiotech stocks were pressured Thursday, with NASDAQ Biotechnology Index falling 3%. Weakness outpaced softness in other areas, with Nasdaq composite lower by only 0.45%.
Nasdaq Biotech currently trades at 2537, just north of its year to date low of 2517 -- a level hit on Feb. 11. At that time, Nasdaq traded at... More
